PharmaTutor (December- 2013)
ISSN: 2347 - 7881
Received On: 31/10/2013; Accepted On: 08/11/2013; Published On: 20/12/2013
Authors: Pathak Namita, Kothiyal Preeti
Department of Clinical Pharmacy,
Shri Guru Ram Rai Institute of Technology and Sciences,
Dehradun, Uttarakhand, India, 248001
pathak_namita@ymail.com
ABSTRACT: The prevalence of hypothyroidism is three times higher among women than men. The prevalence in an unselected community population of young, middle aged and elderly individuals is about 1.4 percent and the estimated annual incidence rate is one to two per 1,000 women. Surveys of geriatric populations have yielded estimated prevalence rates for overt hypothyroidism of 0.2 percent to 3 percent. The presentation of symptoms in the elderly may be atypical or absent. The prevalence of subclinical hypothyroidism is estimated to be between 4.0–8.5% of the adult US population without known thyroid disease, and the prevalence increases with age. Up to 20% of women over the age of 60 are estimated to have subclinical hypothyroidism. Caucasians are more likely to have subclinical hypothyroidism than non-Caucasians. The risk is highest in those with type I diabetes mellitus, a family history of thyroid disease or head/neck cancers treated with external beam radiation. Other risk factors include previous radioactive iodine treatment or thyroid surgery. Interestingly, about 20% of patients on thyroid medications are both over replaced and underreplaced. Because of the high incidence of thyroid disease, The American Thyroid Association recommends measuring thyroid function on all adults beginning at age 35 years and every 5 years thereafter noting that more frequent screening may be appropriate in high risk groups. The treatment of subclinical hypothyroidism has been controversialbut more recent data suggest there are increased risks of ischemic heart disease in untreated patients and that a more aggressive approach to treatment would be appropriate. In contrast, subclinical hyperthyroidism has morewell understood risks of atrial fibrillation and flutter and so should be more aggressively treated.
How to cite this article: Pathak N, Kothiyal P, Thyroid Dysfunctions and its Monitoring, PharmaTutor, 2013, 1(2), 23-38
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1.Watson, S., & Miller, K. The endocrine system. Westport, CT: Greenwood Press, 2004
2.Miot, F., Dupuy, C., Dumont, J., &Rousset, B. Thyroid hormone synthesis and secretion. In Thyroid disease manager. Retrieved from; thyroid manager.org/Chapter2/2-frame.htm., 2010
3.Greer, M. A. The thyroid gland. New York: Raven Press., 1990
4.Bastemir, M., Akin, F., Alkis, E., &Kaptanoglu, B. Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Medical Weekly, 2007, 137, 431-434.
5.Fox, C. S., Pencina, M. J., D'Agostino, R. B., Murabito, J. M., Seely, E. W., Pearce, E. N., &Vasan, R. S. Relations of thyroid function to body weight: Cross-sectionaland longitudinal observations in a community-based sample. Archives of Internal Medicine, 2008, 168(6), 587-592.
6.Iacobellis, G., Ribaudo, M. C., Zappaterreno, A., Iannucci, C. V., &Leonetti, F.Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clinical Endocrinology, 2005, 62, 487-491. doi:10.1111/j.1365-2265.2005.02247.x
7.Hadj-Kacem, H., Rebuffat, S., Mnif-Feki, M., Belguith-Maalej, S., Ayadi, H., &Peraldi-Roux, S. Autoimmune thyroid diseases: Genetic susceptibility of thyroidspecific genes and thyroid autoantigens contributions. International Journal of Immunogenetics, 2009, 36(2), 85-96. doi:10.1111/j.1744-313X.2009.00830.x
8.Camargo, R. Y., Tomimori, E. K., Neves, S. C., Ileana, G. S. R., Galrao, A. L., Knobel, M., & Medeiros-Neto, G. Thyroid and the environment: exposure to excessive nutritional iodine increases the prevalence of thyroid disorders in Sao Paulo, Brazil. European Journal of Endocrinology, 2008, 159(3), 293-299. doi:10.1530/eje-08-0192
9.American Thyroid Association. Hypothyroidism. Retrieved from thyroid.org/patients/patient_brochures/hypothyroidism.html, 2008c
10.American Thyroid Association. Hyperthyroidism. Retrieved from thyroid.org/patients/patient_brochures/hyperthyroidism.html, 2008b
11. American Thyroid Association. Cancer of the thyroid. Retrieved from thyroid.org/patients/patient_brochures/cancer_of_thyroid.html, 2008a
12. Zimmermann, M. B. Symposium on 'geographical and geological influences on nutrition': Iodine deficiency in industrialized countries. The Proceedings of the Nutrition Society, 2010, 69, 133-143. doi:10.1017/s0029665109991819
13.Zimmermann, M. B., Jooste, P. L., &Pandav, C. S. Iodine-deficiency disorders. Lancet, 2008, 372, 1251-1262. doi:10.1016/s0140-6736(08)61005-3
14. Camargo, R. Y., Tomimori, E. K., Neves, S. C., Ileana, G. S. R., Galrao, A. L., Knobel, M.,& Medeiros-Neto, G. Thyroid and the environment: exposure to excessive nutritional iodine increases the prevalence of thyroid disorders in Sao Paulo, Brazil. European Journal of Endocrinology, 2008, 159(3), 293-299. doi:10.1530/eje-08-0192
15.Laurberg, P., Jorgensen, T., Perrild, H., Ovesen, L., Knudsen, N., Pedersen, I. B., . . Vejbjerg, P. The Danish investigation on iodine intake and thyroid disease, DanThyr: Status and perspectives. European Journal of Endocrinology, 2006, 155(2), 219- 228. doi:10.1530/eje.1.02210
16. Pedersen, I. B., Knudsen, N., Jorgensen, T., Perrild, H., Ovesen, L., &Laurberg, P. Large differences in incidences of overt hyper- and hypothyroidism associated with a small difference in iodine intake: A prospective comparative register-based population survey. Journal of Clinical Endocrinology and Metabolism, 2002, 87, 4462- 4469. doi:10.1210/jc.2002-020750
17.Alsayed, A., Gad, A. M., Abdel-Baset, H., Abdel-Fattah, A., Ahmed, A., &Azab, A. Excess urinary iodine is associated with autoimmune subclinical hypothyroidism among Egyptian women. Endocrinology Journal, 2008, 55, 601-605.
18.Shan, Z. Y., Li, Y. S., Wang, Z. Y., Jin, Y., Guan, H. X., Hu, F. N., . . . Teng, W. P. Effect of different iodine intake on the prevalence of hypothyroidism in 3 counties in China. Chinese Medical Journal, 2005, 118, 1918-1920.
19. Laurberg, P., Pedersen, K. M., Hreidarsson, A., Sigfusson, N., Iversen, E., & Knudsen, P. R. Iodine intake and the pattern of thyroid disorders: A comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. Journal of Clinical Endocrinology and Metabolism, 1998, 83, 765-769.
20. Vejbjerg, P., Knudsen, N., Perrild, H., Laurberg, P., Carle, A., Pedersen, I. B., . . . Jorgensen, T. Lower prevalence of mild hyperthyroidism related to a higher iodine intake in the population: prospective study of a mandatory iodization programme. Clinical Endocrinology, 2009, 71, 440-445. doi:10.1111/j.1365-2265.2008.03493.x
21. Blount, B. C., Pirkle, J. L., Osterloh, J. D., Valentin-Blasini, L., & Caldwell, K. L. Urinary perchlorate and thyroid hormone levels in adolescent and adult men and women living in the United States. Environmental Health Perspectives, 2006, 114, 1865- 1871. doi:10.1289/ehp.9466
22. Bunevicius, A., Peceliuniene, J., Mickuviene, N., Girdler, S. S., &Bunevicius, R. The association of thyroid immunity with blood pressure and body mass index in primary care patients. Endocrine Research, 2008, 33(3), 93-103. doi:10.1080/07435800802534126.
23. Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., &Braverman, L. E. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism, 2002, 87, 489- 499.
24. Shon, H. S., Jung, E. D., Kim, S. H., & Lee, J. H. Free T4 is negatively correlated with body mass index in euthyroid women. Korean Journal of Internal Medicine, 2008, 23(2), 53-57.
25.Schectman, J. M., Kallenberg, G. A., Hirsch, R. P., &Shumacher, R. J. Report of an association between race and thyroid stimulating hormone level. American Journal of Public Health, 1991, 81, 505-506.
26. Sichieri, R., Baima, J., Marante, T., De Vasconcellos, M. T. L., Moura, A. S., &Vaisman, M. Low prevalence of hypothyroidism among black and mulatto people in a population-based study of Brazilian women. Clinical Endocrinology, 2007, 66, 803-807. doi:10.1111/j.1365-2265.2007.02816.x
27. Belin, R. M., Astor, B. C., Powe, N. R., &Ladenson, P. W. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism, 2004, 89, 6077-6086. doi:10.1210/jc.2004-0431
28.De Pergola, G., Ciampolillo, A., Paolotti, S., Trerotoli, P., &Giorgino, R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clinical Endocrinology, 2007, 67(2), 265-269. doi:10.1111/j.1365-2265.2007.02874.x
29. Nyrnes, A., Jorde, R., &Sundsfjord, J. Serum TSH is positively associated with BMI. International Journal of Obesity, 2006, 30(1), 100-105. doi:10.1038/sj.ijo. 0803112
30.Makepeace, A. E., Bremner, A. P., O'Leary, P., Leedman, P. J., Feddema, P., Michelangeli, V., & Walsh, J. P. Significant inverse relationship between serum free T4 concentration and body mass index in euthyroid subjects: Differences between smokers and nonsmokers. Clinical Endocrinology, 2008, 69, 648-652. doi:10.1111/j.1365- 2265.2008.03239.x
31. Flegal, K. M., Carroll, M. D., Ogden, C. L., & Curtin, L. R. Prevalence and trends in obesity among US adults, 1999-2008. Journal of the American Medical Association, 2010, 303(3), 235-241. doi:10.1001/jama.2009.2014
32.Chikunguwo, S., Brethauer, S., Nirujogi, V., Pitt, T., Udomsawaengsup, S., Chand, B., &Schauer, P. Influence of obesity and surgical weight loss on thyroid hormone levels. Surgery for Obesity and Related Diseases, 2007, 3, 631–635.
33. Bianco, A. C., Maia, A. L., Da Silva, W. S., &Christoffolete, M. A. Adaptive activation of thyroid hormone and energy expenditure. Bioscience Reports, 2005, 25(3-4), 191-208. doi:10.1007/s10540-005-2885-6
34. Al-Adsani, H., Hoffer, L. J., & Silva, J. E. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. Journal of Clinical Endocrinology and Metabolism, 1997, 82, 1118-1125. doi:10.1210/jc.82.4.1118
35.Knudsen, N., Laurberg, P., Rasmussen, L. B., Bulow, I., Perrild, H., Ovesen, L., & Jorgensen, T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. Journal of Clinical Endocrinology and Metabolism, 2005, 90, 4019-4024. doi:10.1210/jc.2004-2225
36. Nannipieri, M., Cecchetti, F., Anselmino, M., Camastra, S., Niccolini, P., Lamacchia, M. Ferrannini, E. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: Effects of weight loss. International Journal of Obesity, 2009, 33, 1001-1006. doi:10.1038/ijo.2009.140
37. Bastemir, M., Akin, F., Alkis, E., &Kaptanoglu, B. Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Medical Weekly, 2007, 137, 431-434.
38. Rotondi, M., Leporati, P., La Manna, A., Pirali, B., Mondello, T., Fonte, R., . . .Chiovato, L. Raised serum TSH levels in patients with morbid obesity: Is it enough to diagnose subclinical hypothyroidism? European Journal of Endocrinology, 2009, 160, 403- 408. doi:10.1530/eje-08-0734
39. Iacobellis, G., Ribaudo, M. C., Zappaterreno, A., Iannucci, C. V., &Leonetti, F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clinical Endocrinology, 2005, 62, 487-491. doi:10.1111/j.1365-2265.2005.02247.x
40. Fox, C. S., Pencina, M. J., D'Agostino, R. B., Murabito, J. M., Seely, E. W., Pearce, E. N., &Vasan, R. S. Relations of thyroid function to body weight: Cross-sectional and longitudinal observations in a community-based sample. Archives of Internal Medicine, 2008, 168(6), 587-592.
41. Sari, R., Balci, M. K., Altunbas, H., &Karayalcin, U. The effect of body weight and weight loss on thyroid volume and function in obese women. Clinical Endocrinology, 2003, 59, 258-262. doi:10.1046/j.1365-2265.2003.01836.x
42. Toward Optimized Practice Clinical Practice Guideline Working Group. Clinical Practice Guideline: Investigation and Management of Primary Thyroid Dysfunction. Toward Optimized Practice Program, Edmonton: AB, 2008 Update.
43. Dufour D. Laboratory Tests of Thyroid Function: Uses and limitations. EndocrinolMetabClin N AM. 2007; 36:579- 594.
44.Thyroid Foundation of Canada. Health Guides on Thyroid Disease; thyroid.ca/Guides/HG02.html#1, Accessed March 5 2009.
45.Rehman S, Cope D, Senseney A, et al. Thyroid Disorders in Elderly Patients, S Med J 2005 ; 98(5):543-549.
46. OntAssoc of Medical Laboratories. Guideline for the Use of Laboratory Tests to Detect Thyroid Dysfunction CLP 015, Revised July 2007.
47. Kaplan MM. Clinical perspectives in the diagnosis of thyroid disease. ClinChem 1999;45(8):1377-1383.
48. Ogedebe H. Thyroid function test: a clinical lab perspective. Medical Laboratory Observer, February, 2007:10-19.
49. Muller AF, Bergout A, Wiersinga WM, et al. Thyroid Function Disorders- Guidelines of the Netherlands Association of Internal Medicine. The Netherlands Journal of Medicine. 2008;66(3):134-142.
50.Surks M. Ortiz, E., Daniels, G. et al. Subclinical Thyroid Disease; Scientific Review and Guidelines for diagnosis and Management. JAMA. 2004;291(2):228-238.
51.Villar HCCE, Saconato H, Valente O. et al. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Datatbase of Systematic Reviews. 2007:3.
52.Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. ClinEndocrinol. 1995;43:55-68.
53. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331(19):1249-52.
54. Toft AD. Subclinical hyperthyroidism. N Engl J Med. 2001;345(7):512-516.
55. Hoogendoorn E, den Heijer M, van Dijk A. et al. Subclinical Hyperthyroidism: to treat or not to treat? Postgrad Med J. 2004;80:394-398.
56. Biondi B. European Journal of Endocrinology. 2008;159:343–345.
57. Use of Thyroid Function Tests Gidelines Development Group. UK Guidelines for the Use of Thyroid Function Tests, acb.org.uk/docs/TFTguidelinefinal.pdf, 2006.
58.Fauci A, Harrison TR. Harrison’s Principles of Internal Medicine, 17th edition, NY:McGraw-Hill Professional; 2008.
59.Abalovich M, Amino N, Barbour L, et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J ClinEndocrinolMetab. 2007;92(8):S1-S47.
60.Abalovich M, Amino N, Barbour L, et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J ClinEndocrinolMetab. 2007;92(8):S1-S47.
61. ATA Public Health Committee Statement. Haddow study of maternal hypothyroidism during pregnancy. Thyroid. 1999;9(9):971-972.
62. Davies TF. The ATA, the Endocrine Society, and the AACE confuse endocrinologists on thyroid disease in pregnancy. Thyroid. 2000;10(2):107.
63.Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Eng J Med. 1999;341(8):549- 555.
64.Canadian Task Force on the Periodic Health Examination. Screening for Thyroid Disorders and Thyroid Cancer in Asymptomatic Adults in The Canadian Guide to Clinical Preventive Health Care. 2003, Health Canada.
65. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services: an Assessment of the Effectiveness of 169 Interventions. Williams & Wilkins, Baltimore, MD, 2004.
66. Reid, Jeri R, Wheeler, Stephen F. Hyperthyroidism: Diagnosis and Treatment. American Family Physician; 2005, Vol. 72 Issue 4, p623-630.
67.US Preventative Services Task Force, Screening for thyroid disease: recommendation statement. Ann Intern Med 2004, 140:125-127
68. Chu JW, Crapo LM, The treatment of subclinical hypothyroidism is seldom necessary J ClinEndocrinolMetab, 2001, 86:4591-4599
69. McDermott MT, Ridgway EC, Subclinical hypothyroidism is mild thyroid failure and should be treated, J Clin Endocrinol Metab, 2001, 86:4585-90
70.Imaizumi M et al, J Clin Endocirnol Metab, 2004. 89:3365-3370
71. Frost L, Vestergaard L, Hyperthyroidism and risk of atrial fibrillation or flutter, Arch Intern Med, 2004, 164:1675-1678
72. Biondi B et al, Invited review: subclinical hyperthyroidism: clinical features and treatment options, European Journal of Endocrinology, 2005, 152:1- 9
73. Haddow JE et al, Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child, N Engl J Med, 1999, 341:549-555
74. Alexander EK et al, Timing and magnitude of increase in levothyroxine requirements during pregnancy in women with hypothyroidism, N Engl J Med 2004, 351:241-249
75. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997; 126:63.
76. Martino E et al, The effects of amiodarone on the thyroid. Endocr Rev 2001; 22:240.
77. Bocchetta A et al. Thyroid abnormalities during chronic lithium treatment. ActaPsychiatrScand 1991; 83:193.
78. Bini EJ, Mehandru S. Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C. Arch Intern Med 2004; 164:2371-2376.
79. Mazzaferri E, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J ClinEndocrinolMetab 2001; 86:1447-1463
.png)
